Keywords
Last Name
Institution

Jorge E. Gomez

TitleSENIOR FACULTY
InstitutionMount Sinai
DepartmentHematology and Medical Oncology
Address1470 Madison Avenue
3rd floor
New York NY 10029

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gomez J, Soledispa C. Redirection of anomalous venous pulmonary flow to left atrium using a vascular plug II. J Invasive Cardiol. 2012 May; 24(5):E96-8.
      View in: PubMed
    2. Santos ES, Gomez JE, Raez LE. Targeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitor. Invest New Drugs. 2012 Jun; 30(3):1261-9.
      View in: PubMed
    3. Gomez JE, Gentile JI. Patent ductus arteriosus associated with aberrant right subclavian artery: two cases, one successful interventional closure of PDA?. J Invasive Cardiol. 2011 Jan; 23(1):E246-9.
      View in: PubMed
    4. Gomez JE, Sandoval JE. New approaches to prepare hydride silica. Anal Chem. 2010 Sep 1; 82(17):7444-51.
      View in: PubMed
    5. Bastos BR, Hatoum GF, Walker GR, Tolba K, Takita C, Gomez J, Santos ES, Lopes G, Raez LE. Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung cancer. J Thorac Oncol. 2010 Apr; 5(4):533-9.
      View in: PubMed
    6. Tinoco Y, Razuri H, Ortiz EJ, Gomez J, Widdowson MA, Uyeki T, Laguna-Torres VA, Kochel TJ, Gilman RH, Montgomery JM. Preliminary population-based epidemiological and clinical data on 2009 pandemic H1N1 influenza A (pH1N1) from Lima, Peru. Influenza Other Respir Viruses. 2009 Nov; 3(6):253-6.
      View in: PubMed
    7. Gomez J, Bl├╝guermann J. Percutaneous occlusion of patent ductus arteriosus with the Nit-Ccclud device in an adult patient. J Invasive Cardiol. 2007 Nov; 19(11):E335-7.
      View in: PubMed
    8. Cassileth BR, Deng GE, Gomez JE, Johnstone PA, Kumar N, Vickers AJ. Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):340S-354S.
      View in: PubMed
    9. Milton DT, Riely GJ, Azzoli CG, Gomez JE, Heelan RT, Kris MG, Krug LM, Pao W, Pizzo B, Rizvi NA, Miller VA. Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer. Cancer. 2007 Aug 1; 110(3):599-605.
      View in: PubMed
    10. Azzoli CG, Krug LM, Gomez J, Miller VA, Kris MG, Ginsberg MS, Henry R, Jones J, Tyson L, Dunne M, Pizzo B, Farmer A, Venkatraman E, Steffen R, Sirotnak FM. A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors. Clin Cancer Res. 2007 May 1; 13(9):2692-8.
      View in: PubMed
    11. Hurria A, Fleming MT, Baker SD, Kelly WK, Cutchall K, Panageas K, Caravelli J, Yeung H, Kris MG, Gomez J, Miller VA, D'Andrea G, Scher HI, Norton L, Hudis C. Pharmacokinetics and toxicity of weekly docetaxel in older patients. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):6100-5.
      View in: PubMed
    12. Milton DT, Azzoli CG, Heelan RT, Venkatraman E, Gomez JE, Kris MG, Krug LM, Pao W, Rizvi NA, Dunne M, Miller VA. A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer. Cancer. 2006 Sep 1; 107(5):1034-41.
      View in: PubMed
    13. Fury MG, Solit DB, Su YB, Rosen N, Sirotnak FM, Smith RP, Azzoli CG, Gomez JE, Miller VA, Kris MG, Pizzo BA, Henry R, Pfister DG, Rizvi NA. A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2007 Mar; 59(4):467-75.
      View in: PubMed
    14. Krisht AF, Gomez J, Partington S. Outcome of surgical clipping of unruptured aneurysms as it compares with a 10-year nonclipping survival period. Neurosurgery. 2006 Feb; 58(2):207-16; discussion 207-16.
      View in: PubMed
    15. Krug LM, Miller VA, Patel J, Crapanzano J, Azzoli CG, Gomez J, Kris MG, Heelan RT, Pizzo B, Tyson L, Sheehan C, Ross JS, Venkatraman E. Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma. Cancer. 2005 Nov 15; 104(10):2149-55.
      View in: PubMed
    16. Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, Rodin M, Panageas KS, Holland JC, Saltz L, Kris MG, Noy A, Gomez J, Jakubowski A, Hudis C, Kornblith AB. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005 Nov 1; 104(9):1998-2005.
      View in: PubMed
    17. Krug LM, Crapanzano JP, Azzoli CG, Miller VA, Rizvi N, Gomez J, Kris MG, Pizzo B, Tyson L, Dunne M, Heelan RT. Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial. Cancer. 2005 May 15; 103(10):2128-31.
      View in: PubMed
    18. Gomez J. Use of performance-enhancing substances. Pediatrics. 2005 Apr; 115(4):1103-6.
      View in: PubMed
    19. Milton DT, Kris MG, Gomez JE, Feinstein MB. Prompt control of bronchorrhea in patients with bronchioloalveolar carcinoma treated with gefitinib (Iressa). Support Care Cancer. 2005 Jan; 13(1):70-2.
      View in: PubMed
    20. Krug LM, Ragupathi G, Hood C, Kris MG, Miller VA, Allen JR, Keding SJ, Danishefsky SJ, Gomez J, Tyson L, Pizzo B, Baez V, Livingston PO. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 1):6094-100.
      View in: PubMed
    21. Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol. 2004 Mar 15; 22(6):1103-9.
      View in: PubMed
    22. Patel JD, Krug LM, Azzoli CG, Gomez J, Kris MG, Miller VA. Targeting lethal minimal residual disease in small cell lung cancer. Semin Oncol. 2003 Feb; 30(1):79-85.
      View in: PubMed
    23. Gomez JE. Performance-enhancing substances in adolescent athletes. Tex Med. 2002 Feb; 98(2):41-6.
      View in: PubMed
    24. Gomez JE, Neufeld MD, Cosby BK. Ability of middle-school soccer players to localize overuse leg pain correctly using a graphic self-report form. Percept Mot Skills. 1996 Feb; 82(1):335-8.
      View in: PubMed
    25. Gomez JE. Bilateral anterior inferior iliac spine avulsion fractures. Med Sci Sports Exerc. 1996 Feb; 28(2):161-4.
      View in: PubMed
    26. Allison DB, Gomez JE, Heshka S, Babbitt RL, Geliebter A, Kreibich K, Heymsfield SB. Decreased resting metabolic rate among persons with Down Syndrome. Int J Obes Relat Metab Disord. 1995 Dec; 19(12):858-61.
      View in: PubMed
    27. Gomez JE, Landry GL, Bernhardt DT. Critical evaluation of the 2-minute orthopedic screening examination. Am J Dis Child. 1993 Oct; 147(10):1109-13.
      View in: PubMed
    28. Gomez JE, Thurston GB. Comparisons of the oscillatory shear viscoelasticity and composition of pathological synovial fluids. Biorheology. 1993 Sep-Dec; 30(5-6):409-27.
      View in: PubMed
    Gomez's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067